Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

Liam G Heaney, John Busby, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, Samantha M Walker, Timothy C Hardman, Joseph R Arron, David F Choy, Peter Bradding, Christopher E Brightling, Rekha Chaudhuri, Douglas C Cowan, Adel H Mansur, Stephen J Fowler, Robert M Niven, Peter H Howarth, James L Lordan, Andrew Menzies-gow, Tim W HarrisonDouglas S Robinson, Cecile T J Holweg, John G Matthews, Ian D Pavord, Ian M Adcock, Adnam Azim, Mary Bellamy, Catherine Borg, Michelle Bourne, Clare Connolly, Richard W Costello, Chris J Corrigan, Sarah Davies, Gareth Davies, Kian F Chung, Gabrielle Gainsborough, Traceyanne Grandison, Beverley Hargadon, Avril Horn, Val Hudson, David Jackson, Sebastian Johnston, Geraldine Jones, Paula Mccourt, Maria Nunez, Dominic E Shaw, Katherine Smith, Joel Solis, Roisin Stone, Freda Yang

Research output: Contribution to journal › Article › peer-review

57 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences